IMVT
Immunovant Inc

2,216
Mkt Cap
$5.51B
Volume
497,897.00
52W High
$29.25
52W Low
$12.72
PE Ratio
-10.10
IMVT Fundamentals
Price
$26.44
Prev Close
$27.08
Open
$26.70
50D MA
$26.36
Beta
1.03
Avg. Volume
1.38M
EPS (Annual)
-$2.73
P/B
5.58
Rev/Employee
$0.00
$1,876.52
Loading...
Loading...

About

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
362

Frequently Asked Questions

What is Market Cap of Immunovant Inc?
What is the 52-week high for Immunovant Inc?
What is the 52-week low for Immunovant Inc?
What is Immunovant Inc stock price today?
What was Immunovant Inc stock price yesterday?
What is the PE ratio of Immunovant Inc?
What is the Price-to-Book ratio of Immunovant Inc?
What is the 50-day moving average of Immunovant Inc?
How many employees does Immunovant Inc have?

Latest IMVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.